Study supports precision radiation therapy in lung cancer
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more...
MD Anderson and Rice launch Cancer Bioengineering...
The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering...
Activating molecular target reverses multiple hallmarks of...
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels...
CAR NK cells with CD28 costimulation improved cell persistence and...
Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting CD70+ cancers...
MD Anderson Research Highlights for June 19, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
MD Anderson’s Institute for Data Science in Oncology...
The Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer Center today announced the...
MD Anderson Research Highlights: EHA 2024 Special Edition
ABSTRACTS: LB3439, LB3442, S131, S132, S136, S164, S222
The University of Texas MD Anderson Cancer Center’s Research Highlights...
MD Anderson celebrates the life and legacy of V. Craig...
Pharmacologist V. Craig Jordan, Ph.D., a professor of Breast Medical Oncology and Molecular and Cellular Oncology at The University of...
MD Anderson and Sibylla Biotech announce strategic...
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover...
Allison Institute announces appointment of two...
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest...
MD Anderson Research Highlights for June 5, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
ASCO: Proton therapy demonstrates advantages in Phase III...
ABSTRACT 6006
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of...